NCT04504942 2026-01-23
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
CytoDyn, Inc.
Phase 2 Completed
CytoDyn, Inc.
Samsung Medical Center
Fudan University
Omico
Baptist Health South Florida
Yonsei University